Cargando…
Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein
Human norovirus (HuNoV) is responsible for more than 95% of outbreaks of acute nonbacterial gastroenteritis worldwide. Despite major efforts, there are no vaccines or effective therapeutic interventions against this virus. Chicken immunoglobulin Y (IgY)-based passive immunization has been shown to b...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563233/ https://www.ncbi.nlm.nih.gov/pubmed/31100802 http://dx.doi.org/10.3390/v11050444 |
_version_ | 1783426503241891840 |
---|---|
author | Zhu, Yang Ma, Yuanmei Lu, Mijia Zhang, Yu Li, Anzhong Liang, Xueya Li, Jianrong |
author_facet | Zhu, Yang Ma, Yuanmei Lu, Mijia Zhang, Yu Li, Anzhong Liang, Xueya Li, Jianrong |
author_sort | Zhu, Yang |
collection | PubMed |
description | Human norovirus (HuNoV) is responsible for more than 95% of outbreaks of acute nonbacterial gastroenteritis worldwide. Despite major efforts, there are no vaccines or effective therapeutic interventions against this virus. Chicken immunoglobulin Y (IgY)-based passive immunization has been shown to be an effective strategy to prevent and treat many enteric viral diseases. Here, we developed a highly efficient bioreactor to generate high titers of HuNoV-specific IgY in chicken yolks using a recombinant vesicular stomatitis virus expressing HuNoV capsid protein (rVSV-VP1) as an antigen. We first demonstrated that HuNoV VP1 protein was highly expressed in chicken cells infected by rVSV-VP1. Subsequently, we found that White Leghorn hens immunized intramuscularly with rVSV-VP1 triggered a high level of HuNoV-specific yolk IgY antibodies. The purified yolk IgY was efficiently recognized by HuNoV virus-like particles (VLPs). Importantly, HuNoV-specific IgY efficiently blocked the binding of HuNoV VLPs to all three types (A, B, and O) of histo-blood group antigens (HBGAs), the attachment factors for HuNoV. In addition, the receptor blocking activity of IgY remained stable at temperature below 70 °C and at pH ranging from 4 to 9. Thus, immunization of hens with VSV-VP1 could be a cost-effective and practical strategy for large-scale production of anti-HuNoV IgY antibodies for potential use as prophylactic and therapeutic treatment against HuNoV infection. |
format | Online Article Text |
id | pubmed-6563233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65632332019-06-17 Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein Zhu, Yang Ma, Yuanmei Lu, Mijia Zhang, Yu Li, Anzhong Liang, Xueya Li, Jianrong Viruses Article Human norovirus (HuNoV) is responsible for more than 95% of outbreaks of acute nonbacterial gastroenteritis worldwide. Despite major efforts, there are no vaccines or effective therapeutic interventions against this virus. Chicken immunoglobulin Y (IgY)-based passive immunization has been shown to be an effective strategy to prevent and treat many enteric viral diseases. Here, we developed a highly efficient bioreactor to generate high titers of HuNoV-specific IgY in chicken yolks using a recombinant vesicular stomatitis virus expressing HuNoV capsid protein (rVSV-VP1) as an antigen. We first demonstrated that HuNoV VP1 protein was highly expressed in chicken cells infected by rVSV-VP1. Subsequently, we found that White Leghorn hens immunized intramuscularly with rVSV-VP1 triggered a high level of HuNoV-specific yolk IgY antibodies. The purified yolk IgY was efficiently recognized by HuNoV virus-like particles (VLPs). Importantly, HuNoV-specific IgY efficiently blocked the binding of HuNoV VLPs to all three types (A, B, and O) of histo-blood group antigens (HBGAs), the attachment factors for HuNoV. In addition, the receptor blocking activity of IgY remained stable at temperature below 70 °C and at pH ranging from 4 to 9. Thus, immunization of hens with VSV-VP1 could be a cost-effective and practical strategy for large-scale production of anti-HuNoV IgY antibodies for potential use as prophylactic and therapeutic treatment against HuNoV infection. MDPI 2019-05-16 /pmc/articles/PMC6563233/ /pubmed/31100802 http://dx.doi.org/10.3390/v11050444 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhu, Yang Ma, Yuanmei Lu, Mijia Zhang, Yu Li, Anzhong Liang, Xueya Li, Jianrong Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein |
title | Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein |
title_full | Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein |
title_fullStr | Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein |
title_full_unstemmed | Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein |
title_short | Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein |
title_sort | efficient production of human norovirus-specific igy in egg yolks by vaccination of hens with a recombinant vesicular stomatitis virus expressing vp1 protein |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563233/ https://www.ncbi.nlm.nih.gov/pubmed/31100802 http://dx.doi.org/10.3390/v11050444 |
work_keys_str_mv | AT zhuyang efficientproductionofhumannorovirusspecificigyineggyolksbyvaccinationofhenswitharecombinantvesicularstomatitisvirusexpressingvp1protein AT mayuanmei efficientproductionofhumannorovirusspecificigyineggyolksbyvaccinationofhenswitharecombinantvesicularstomatitisvirusexpressingvp1protein AT lumijia efficientproductionofhumannorovirusspecificigyineggyolksbyvaccinationofhenswitharecombinantvesicularstomatitisvirusexpressingvp1protein AT zhangyu efficientproductionofhumannorovirusspecificigyineggyolksbyvaccinationofhenswitharecombinantvesicularstomatitisvirusexpressingvp1protein AT lianzhong efficientproductionofhumannorovirusspecificigyineggyolksbyvaccinationofhenswitharecombinantvesicularstomatitisvirusexpressingvp1protein AT liangxueya efficientproductionofhumannorovirusspecificigyineggyolksbyvaccinationofhenswitharecombinantvesicularstomatitisvirusexpressingvp1protein AT lijianrong efficientproductionofhumannorovirusspecificigyineggyolksbyvaccinationofhenswitharecombinantvesicularstomatitisvirusexpressingvp1protein |